APOB and chronic kidney disease: In summary, the metabolic profile of CKD appears to be characterized by multiple effects on lipoproteins and their lipidic content, with substantially increased absolute numbers of, and the lipids within, atherosclerotic Apo-B containing lipoproteins as well as Apo-B, and increased concentrations of the smallest VLDL particles.